1 | Case | 1.66% | |
2 | Report | 1.57% | |
3 | Study | 1.32% | |
4 | Disease | 1.16% | |
5 | Cancer | 0.91% | |
6 | Patients | 0.91% | |
7 | New | 0.75% | |
8 | ASCO | 0.66% | |
9 | Renal | 0.58% | |
10 | According | 0.58% | |
11 | Therapy | 0.58% | |
12 | Treatment | 0.5% | |
13 | May | 0.5% | |
14 | Syndrome | 0.5% | |
15 | Review | 0.5% | |
16 | Carcinoma | 0.5% | |
17 | Use | 0.41% | |
18 | Clinical | 0.41% | |
19 | Risk | 0.41% | |
20 | Gene | 0.41% | |
21 | Alzheimer’s | 0.33% | |
22 | Artery | 0.33% | |
23 | ADHD | 0.33% | |
24 | Health | 0.33% | |
25 | Dysfunction | 0.33% | |
26 | Detection | 0.33% | |
27 | Research | 0.33% | |
28 | Management | 0.33% | |
29 | Status | 0.25% | |
30 | Rare | 0.25% | |
31 | Lower | 0.25% | |
32 | Protein | 0.25% | |
33 | Bone | 0.25% | |
34 | Mediterranean | 0.25% | |
35 | Cervical | 0.25% | |
36 | Reconstruction | 0.25% | |
37 | Advanced | 0.25% | |
38 | Long-Term | 0.25% | |
39 | Tumor | 0.25% | |
40 | Potential | 0.25% | |
41 | Recurrent | 0.25% | |
42 | Trial | 0.25% | |
43 | Cell | 0.25% | |
44 | Role | 0.25% | |
45 | Chronic | 0.25% | |
46 | Immune | 0.25% | |
47 | Could | 0.25% | |
48 | Retrospective | 0.25% | |
49 | NSCLC | 0.25% | |
50 | Checkpoint | 0.25% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Novel Molecular Assay Guides Adjuvant Chemo in NSCLC
HMP Global Learning Network
2025-06-01 02:30:08
Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy
The ASCO Post
2025-06-01 00:00:04